SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Pronged cancer drug enters human trials
Disease control Recruiting nowThis study is testing the safety and effectiveness of a new investigational drug called GI-101 for people with advanced or metastatic solid tumors. The drug is designed to work in two ways to help the immune system fight cancer. Researchers will test it alone and in combination w…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New cancer drug enters human testing for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people testing an experimental drug called ABBV-324 for advanced liver cancer or a type of lung cancer. The main goals are to find a safe dose, see how the body processes the drug, and check if it helps shrink tumors. The study will enroll about 232 adu…
Matched conditions: SQUAMOUS CELL NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC